| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Department of Ophthalmology, Harvard Medical School, and the Massachusetts Eye and Ear Infirmary, Boston, MA.
We prospectively studied 60 white patients living in New England who presented with uncomplicated optic neuritis (ON) to determine the risk of developing multiple sclerosis (MS). The diagnoses of ON and MS were made solely on the basis of clinical criteria. Patients were followed for a mean of 14.9 years. Life table analysis indicated that 74% of the women and 34% of the men will have developed MS 15 years after their attack of ON. The risk of developing MS was 3. 4 times greater for women than for men. Onset of ON between the ages of 21 and 40 years may have had a modest effect in increasing the risk of developing MS. Recurrence of ON did not appear to affect the risk.
Address correspondence and reprint requests to Dr. Rizzo, Massachusetts Eye and Ear Infirmary, 243 Charles Street, Boston, MA 02114.
Received January 28, 1987. Accepted for publication in final form May 4, 1987.
This article has been cited by other articles:
|
|
 |
|
  N. J. Volpe The Optic Neuritis Treatment Trial: A Definitive Answer and Profound Impact With Unexpected Results Arch Ophthalmol, July 1, 2008; 126(7): 996 - 999. [Full Text] [PDF]
|
|
|
|
 |
|
 The Optic Neuritis Study Group Multiple Sclerosis Risk After Optic Neuritis: Final Optic Neuritis Treatment Trial Follow-up Arch Neurol, June 1, 2008; 65(6): 727 - 732. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D.A. Jacobs and S.L. Galetta Neuro-Ophthalmology for Neuroradiologists AJNR Am. J. Neuroradiol., January 1, 2007; 28(1): 3 - 8. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Yarilin, J. Valiando, and D. N. Posnett A Mouse Herpesvirus Induces Relapse of Experimental Autoimmune Arthritis by Infection of the Inflammatory Target Tissue J. Immunol., October 15, 2004; 173(8): 5238 - 5246. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Optic Neuritis Study Group Neurologic Impairment 10 Years After Optic Neuritis Arch Neurol, September 1, 2004; 61(9): 1386 - 1389. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E T Lim, D Grant, M Pashenkov, G Keir, E J Thompson, M Soderstrom, and G Giovannoni Cerebrospinal fluid levels of brain specific proteins in optic neuritis Multiple Sclerosis, June 1, 2004; 10(3): 261 - 265. [Abstract] [PDF]
|
|
|
|
|
|
A. Minneboo, F. Barkhof, C. H. Polman, B. M. J. Uitdehaag, D. L. Knol, and J. A. Castelijns Infratentorial Lesions Predict Long-term Disability in Patients With Initial Findings Suggestive of Multiple Sclerosis Arch Neurol, February 1, 2004; 61(2): 217 - 221. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. A. Levin and S. Lessell Risk of Multiple Sclerosis After Optic Neuritis JAMA, July 16, 2003; 290(3): 403 - 404. [Full Text] [PDF]
|
|
|
|
|
|
Optic Neuritis Study Group* High- and Low-Risk Profiles for the Development of Multiple Sclerosis Within 10 Years After Optic Neuritis: Experience of the Optic Neuritis Treatment Trial Arch Ophthalmol, July 1, 2003; 121(7): 944 - 949. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y P Jin, J de Pedro-Cuesta, Y H Huang, and M Soderstrom Predicting multiple sclerosis at optic neuritis onset Multiple Sclerosis, April 1, 2003; 9(2): 135 - 141. [Abstract] [PDF]
|
|
|
|
|
|
CHAMPS Study Group Predictors of short-term disease activity following a first clinical demyelinating event: analysis of the CHAMPS placebo groupy Multiple Sclerosis, October 1, 2002; 8(5): 405 - 409. [Abstract] [PDF]
|
|
|
|
 |
|
 P. A. Brex, O. Ciccarelli, J. I. O'Riordan, M. Sailer, A. J. Thompson, and D. H. Miller A Longitudinal Study of Abnormalities on MRI and Disability from Multiple Sclerosis N. Engl. J. Med., January 17, 2002; 346(3): 158 - 164. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. I. Kaufman, J. D. Trobe, E. R. Eggenberger, and J. N. Whitaker Practice parameter: The role of corticosteroids in the management of acute monosymptomatic optic neuritis: Report of the Quality Standards Subcommittee of the American Academy of Neurology Neurology, June 13, 2000; 54(11): 2039 - 2044. [Full Text] [PDF]
|
|
|
|
 |
|
 W I McDonald Physicians, subsequence and consequence J. Neurol. Neurosurg. Psychiatry, September 1, 1999; 67(3): 282 - 289. [Full Text]
|
|
|
|
 |
|
 J. Guy, X. Qi, and W. W. Hauswirth Adeno-associated viral-mediated catalase expression suppresses optic neuritis in experimental allergic encephalomyelitis PNAS, November 10, 1998; 95(23): 13847 - 13852. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J I O'Riordan, N A Losseff, C Phatouros, A J Thompson, I F Moseley, D G MacManus, W I McDonald, and D H Miller Asymptomatic spinal cord lesions in clinically isolated optic nerve, brain stem, and spinal cord syndromes suggestive of demyelination J. Neurol. Neurosurg. Psychiatry, March 1, 1998; 64(3): 353 - 357. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Meeting Report and Proceedings: Multiple Sclerosis Society of Great Britain and Northern Ireland Multiple Sclerosis, August 1, 1996; 2(1): 1 - 55. [PDF]
|
|
|
|
|
|
J. T. Coyle Optic Neuritis Treatment Trial Study Arch Ophthalmol, October 1, 1994; 112(10): 1274 - 1274. [Abstract] [PDF]
|
|
|
|
|
|
R. W. Beck and Optic Neuritis Study Group Optic Neuritis Treatment Trial Study-Reply Arch Ophthalmol, October 1, 1994; 112(10): 1274 - 1275. [Abstract] [PDF]
|
|
|
|
|
|
W. B. Wilson How Much Should We Editorialize? Arch Ophthalmol, March 1, 1994; 112(3): 298 - 299. [Abstract] [PDF]
|
|
|
|
|
|
R. W. Beck, P. A. Cleary, J. D. Trobe, D. I. Kaufman, M. J. Kupersmith, D. W. Paty, C. H. Brown, and The Optic Neuritis Study Group The Effect of Corticosteroids for Acute Optic Neuritis on the Subsequent Development of Multiple Sclerosis N. Engl. J. Med., December 9, 1993; 329(24): 1764 - 1769. [Abstract] [Full Text]
|
|
|
|
|
|
J. F. Rizzo III and S. Lessell Optic Neuritis and Ischemic Optic Neuropathy: Overlapping Clinical Profiles Arch Ophthalmol, December 1, 1991; 109(12): 1668 - 1672. [Abstract] [PDF]
|
|
|
|
|
|
J. Guy, E. A. Ellis, and N. A. Rao Hydrogen Peroxide Localization in Experimental Optic Neuritis Arch Ophthalmol, November 1, 1990; 108(11): 1614 - 1621. [Abstract] [PDF]
|
|
|
|
|
|
W. B. Wilson and D. B. Smith Does Neuroretinitis Rule Out Multiple Sclerosis? Arch Neurol, April 1, 1989; 46(4): 358 - 358. [Abstract] [PDF]
|
|
|
|
|
|
V. C. Parmley Does Neuroretinitis Rule Out Multiple Sclerosis?-Reply Arch Neurol, April 1, 1989; 46(4): 358 - 358. [Abstract] [PDF]
|
|
|
|
|
|
R. W. Beck The Optic Neuritis Treatment Trial Arch Ophthalmol, August 1, 1988; 106(8): 1051 - 1053. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
